Related Experiment Video
Updated: Aug 7, 2026

09:04
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues
K D Joory1, J R Levick, P S Mortimer
1Microvascular Research Laboratories, Department of Physiology, Preclinical Veterinary School, University of Bristol, Bristol.
Lymphatic Research and Biology
|July 1, 2006
Summary
Intracellular vascular endothelial growth factor-C (VEGF-C) protein is widely found in normal human tissues, including muscle, thyroid, and prostate. This broad expression means cancer-related VEGF-C levels require quantitative analysis to indicate lymphatic changes.
Area of Science:
- Cell biology
- Molecular biology
- Histology
Background:
- Vascular endothelial growth factor-C (VEGF-C) is a key regulator of lymphatic endothelial cell growth.
- VEGF-C is known to be present in various cancers, but its distribution in normal human tissues is not well-documented.
- Understanding normal VEGF-C localization is crucial for interpreting its role in disease.
Purpose of the Study:
- To map the expression patterns of intracellular VEGF-C protein in a diverse range of normal human tissues using immunohistochemistry (IHC).
- To establish a baseline for VEGF-C protein distribution in healthy adult tissues.
Main Methods:
- Archived human tissue sections were analyzed using immunohistochemistry (IHC).
- Microwave pretreatment and specific VEGF-C antibody incubation were employed.
- Detection utilized a biotinylated secondary antibody system with diaminobenzidine substrate, targeting the intracellular VEGF-C propeptide.
Main Results:
- Strong intracellular VEGF-C protein expression was observed in the epithelium of the large intestine and mammary ducts, as well as in skeletal muscle, cardiac muscle, thyroid, ovary, and prostate.
- Weaker expression was noted in liver hepatocytes near hepatic venules, vascular smooth muscle, and placenta.
- Consistent expression was not detected in the spleen or thymus.
Conclusions:
- Intracellular VEGF-C protein exhibits widespread expression across numerous normal human adult tissues.
- The presence of VEGF-C in cancer does not automatically signify a prolymphangiogenic effect.
- Demonstrating a prolymphangiogenic role requires evidence of a quantitative change in VEGF-C expression levels.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

